){kind=logo}
){kind=logo}
){kind=logo}
Bouygues Construction Adopts Fingerprint Drug Testing
Bouygues Construction is a global leader in the sector, employing approximately 35,600 people across more than 50 countries and generating €10.3 billion in sales in 2024. Its UK rollout begins with 12 project sites.
Moving Towards a More Practical Approach to Drug Testing
Like many large construction organisations, Bouygues Construction previously relied on third-party testing services. While effective, these approaches often introduce operational challenges, from coordinating external providers to managing site-level delays. The move to an in-house solution reflects a clear shift in priorities. Speed, consistency, and control are now central to how drug testing is managed nationwide.
Fingerprint drug testing is supporting this transition by enabling on-site screening without the need for specialist facilities or external personnel. Sample collection takes place in seconds, with results available in under ten minutes. This allows testing to be carried out as part of normal site operations, rather than as a separate process that disrupts workflow. For organisations managing multiple sites and rotating workforces, this level of flexibility is critical.
Another important factor in Bouygues Construction’s decision was the impact of testing methods on employee experience.
Traditional methods such as urine and saliva drug testing often raise issues of privacy, dignity, and time. Additionally, these methods often require controlled conditions, additional supervision, or extended waiting periods, which can affect both productivity and employee perception.
Fingerprint drug testing provides a non-invasive alternative. The process is quick, discreet, and does not require dedicated facilities. This helps create a more balanced approach that maintains workplace safety without introducing unnecessary friction for employees.
A final key part of the decision-making process was the projected return on investment. A joint analysis compared the cost and operational impact of third-party testing services with an in-house approach. The analysis identified fingerprint drug testing as the clear winner, particularly when considering the ongoing nature of testing programmes across multiple sites. By reducing reliance on external providers and streamlining testing, Bouygues Construction quantified the financial and operational benefits of the transition.
This reinforces an important point. Drug testing is not only a compliance requirement but also an operational process that can be optimised. When implemented effectively, it can reduce downtime, simplify logistics, and support more consistent decision-making across sites.
Supporting Safety Critical Industries
Construction remains one of the most safety-critical industries globally, where the consequences of unsafe behaviour can be life-changing.
Workplace drug testing plays an important role in supporting safety. Slow, intrusive, or difficult-to-manage approaches can limit adoption and reduce overall effectiveness. By focusing on recent drug use within a 16 to 24-hour detection window, fingerprint drug testing allows employers to make critical fitness-for-duty decisions.
Intelligent Fingerprinting’s partnership with Bouygues Construction reflects a shared focus on improving the delivery of workplace drug testing in real-world environments. As the rollout continues across the UK, this collaboration sets a clear foundation for what modern workplace drug testing can look like in practice.
)
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
)
){kind=logo}
)
)
)
)
)
)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}